Search research articles
Contact Us
Filters
Showing results (271-280 of 284) with videos related to
Page
of 29
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
September 9, 2020
Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer
Trevor J Royce, Panayiotis Mavroidis, Kyle Wang, et al.
Plos Neglected Tropical Diseases
|
February 24, 2023
Contextual determinants of mass drug administration performance: Modelling fourteen years of lymphatic filariasis treatments in West Africa
Brian B Fuller, Vance Harris, Caleb Parker, et al.
Nature Communications
|
November 18, 2024
A modular platform for bioluminescent RNA tracking
Lila P Halbers, Kyle H Cole, Kevin K Ng, et al.
The American Journal of Tropical Medicine and Hygiene
|
October 20, 2021
Restarting Neglected Tropical Diseases Programs in West Africa during the COVID-19 Pandemic: Lessons Learned and Best Practices
Achille Kabore, Stephanie L Palmer, Ernest Mensah, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 25, 2021
Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients
Ritchell van Dams, Naomi Y Jiang, Donald B Fuller, et al.
European Urology Oncology
|
April 12, 2026
Extended Follow-up from the Stereotactic Body Radiotherapy for High-risk Localized Carcinoma of the Prostate (SHARP) Consortium: Updated Analysis of 440 Patients
Luca F Valle, Tahmineh Romero-Kalbasi, Tommy Jiang, et al.
Advances in Radiation Oncology
|
September 29, 2021
Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series
Jesus E Juarez, Tahmineh Romero, Constantine A Mantz, et al.
JAMA Network Open
|
February 9, 2019
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer
Amar U Kishan, Audrey Dang, Alan J Katz, et al.
Cancer Treatment Reviews
|
May 9, 2021
Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus
Barbara A Jereczek-Fossa, Giulia Marvaso, Mattia Zaffaroni, et al.
BMJ Global Health
|
May 4, 2023
How well do coverage surveys and programmatically reported mass drug administration coverage match? Results from 214 mass drug administration campaigns in 15 countries, 2008-2017
Kathryn L Zoerhoff, Pamela S Mbabazi, Katherine Gass, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 284) with videos related to
Sort By:
Page
of 29
International Journal of Radiation Oncology, Biology, Physics
|
September 9, 2020
Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer
Trevor J Royce, Panayiotis Mavroidis, Kyle Wang, et al.
Plos Neglected Tropical Diseases
|
February 24, 2023
Contextual determinants of mass drug administration performance: Modelling fourteen years of lymphatic filariasis treatments in West Africa
Brian B Fuller, Vance Harris, Caleb Parker, et al.
Nature Communications
|
November 18, 2024
A modular platform for bioluminescent RNA tracking
Lila P Halbers, Kyle H Cole, Kevin K Ng, et al.
The American Journal of Tropical Medicine and Hygiene
|
October 20, 2021
Restarting Neglected Tropical Diseases Programs in West Africa during the COVID-19 Pandemic: Lessons Learned and Best Practices
Achille Kabore, Stephanie L Palmer, Ernest Mensah, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 25, 2021
Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients
Ritchell van Dams, Naomi Y Jiang, Donald B Fuller, et al.
European Urology Oncology
|
April 12, 2026
Extended Follow-up from the Stereotactic Body Radiotherapy for High-risk Localized Carcinoma of the Prostate (SHARP) Consortium: Updated Analysis of 440 Patients
Luca F Valle, Tahmineh Romero-Kalbasi, Tommy Jiang, et al.
Advances in Radiation Oncology
|
September 29, 2021
Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series
Jesus E Juarez, Tahmineh Romero, Constantine A Mantz, et al.
JAMA Network Open
|
February 9, 2019
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer
Amar U Kishan, Audrey Dang, Alan J Katz, et al.
Cancer Treatment Reviews
|
May 9, 2021
Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus
Barbara A Jereczek-Fossa, Giulia Marvaso, Mattia Zaffaroni, et al.
BMJ Global Health
|
May 4, 2023
How well do coverage surveys and programmatically reported mass drug administration coverage match? Results from 214 mass drug administration campaigns in 15 countries, 2008-2017
Kathryn L Zoerhoff, Pamela S Mbabazi, Katherine Gass, et al.
Page
of 29